BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 27995444)

  • 1. E-Government Attempts in Small Island Developing States: The Rate of Corruption with Virtualization.
    Sari A
    Sci Eng Ethics; 2017 Dec; 23(6):1673-1688. PubMed ID: 27995444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sick regimes and sick people: a multilevel investigation of the population health consequences of perceived national corruption.
    Witvliet MI; Kunst AE; Arah OA; Stronks K
    Trop Med Int Health; 2013 Oct; 18(10):1240-7. PubMed ID: 24016030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digital technology for health sector governance in low and middle income countries: a scoping review.
    Holeman I; Cookson TP; Pagliari C
    J Glob Health; 2016 Dec; 6(2):020408. PubMed ID: 27648255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risk of corruption in public pharmaceutical procurement: how anti-corruption, transparency and accountability measures may reduce this risk.
    Kohler JC; Dimancesco D
    Glob Health Action; 2020; 13(sup1):1694745. PubMed ID: 32194011
    [No Abstract]   [Full Text] [Related]  

  • 5. Covid-19 corruption in the public health sector-emerging evidence from Bangladesh.
    Hossain MM; Rahaman MM; Rahman MJ
    Health Policy Plan; 2023 Aug; 38(7):799-821. PubMed ID: 37243741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring corruption in the South African health sector.
    Rispel LC; de Jager P; Fonn S
    Health Policy Plan; 2016 Mar; 31(2):239-49. PubMed ID: 26104821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating the Underlying Factors of Corruption in the Public Construction Sector: Evidence from China.
    Shan M; Le Y; Yiu KTW; Chan APC; Hu Y
    Sci Eng Ethics; 2017 Dec; 23(6):1643-1666. PubMed ID: 28039612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The environmental Kuznets curve in the presence of corruption in developing countries.
    Masron TA; Subramaniam Y
    Environ Sci Pollut Res Int; 2018 May; 25(13):12491-12506. PubMed ID: 29464597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mainlandization, the ICAC, and the Seriousness Attached by Local Politicians to Corruption in Post-1997 Hong Kong.
    Li L; Lo TW
    Int J Offender Ther Comp Criminol; 2018 May; 62(6):1742-1760. PubMed ID: 28077021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human rights mechanisms for anti-corruption, transparency and accountability: enabling the right to health.
    Sekalala S; Masud H; Bosco RT
    Glob Health Action; 2020; 13(sup1):1699343. PubMed ID: 32194016
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-corruption, Transparency and Accountability: Case Study of Healthcare in the Arab Countries.
    Hunter M; Uwaydah Mardini R; El-Seblani A; Elsayed S
    Glob Health Action; 2020; 13(sup1):1704529. PubMed ID: 32194015
    [No Abstract]   [Full Text] [Related]  

  • 12. Governance in managing public health resources in Brazilian municipalities.
    Avelino G; Barberia LG; Biderman C
    Health Policy Plan; 2014 Sep; 29(6):694-702. PubMed ID: 23411119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "It Keeps Us from Putting Drugs in Pockets": How a Public-Private Partnership for Hospital Management May Help Curb Corruption.
    Vian T; Mcintosh N; Grabowski A
    Perm J; 2017; 21():16-113. PubMed ID: 28746025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An interdisciplinary review of digital technologies to facilitate anti-corruption, transparency and accountability in medicines procurement.
    Mackey TK; Cuomo RE
    Glob Health Action; 2020; 13(sup1):1695241. PubMed ID: 32194014
    [No Abstract]   [Full Text] [Related]  

  • 15. Penta-Helix Model of E-Government in Combating Corruption in Indonesia and Malaysia: The Moderating Effect of Religiosity.
    Purnamasari P; Amran NA; Nu'man AH; Frendika R; Nor MNM; Ismail MS
    F1000Res; 2022; 11():932. PubMed ID: 36505097
    [No Abstract]   [Full Text] [Related]  

  • 16. Corruption and strengthening anti-corruption efforts in healthcare during the pandemic of Covid-19.
    Teremetskyi V; Duliba Y; Kroitor V; Korchak N; Makarenko O
    Med Leg J; 2021 Mar; 89(1):25-28. PubMed ID: 33331228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-corruption, transparency and accountability in health: concepts, frameworks, and approaches.
    Vian T
    Glob Health Action; 2020; 13(sup1):1694744. PubMed ID: 32194010
    [No Abstract]   [Full Text] [Related]  

  • 18. Auditing Nicaragua's anti-corruption struggle, 1998 to 2009.
    Arosteguí J; Hernandez C; Suazo H; Cárcamo A; Reyes RM; Andersson N; Ledogar RJ
    BMC Health Serv Res; 2011 Dec; 11 Suppl 2(Suppl 2):S3. PubMed ID: 22375610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opening the Policy Window to Mobilize Action Against Corruption in the Health Sector Comment on "We Need to Talk About Corruption in Health Systems".
    Mackey TK
    Int J Health Policy Manag; 2019 Nov; 8(11):668-671. PubMed ID: 31779293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corruption in health systems.
    Nishtar S
    Lancet; 2010 Sep; 376(9744):874. PubMed ID: 20833301
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.